Clinical approval
https://metamachine.sukanthoriginal.com/guide/shortage-k15.html

Clinical approval is the health output that the model assumes can be provided under the relevant approval constraints.

Conditional constraint (https://metamachine.sukanthoriginal.com/guide/what-the-numbers-mean.html#constraint)
Calculated output blocked
$19.6Tin this scenario, one constraint

Range across tested cases
$4.9T – $19.6T3 cases; not a probability interval

This is a conditional test of the chosen target economy. It does not predict how much GDP will be lost. Changing the target mix, supply assumptions or production method can change the result.
[E] Estimated (https://metamachine.sukanthoriginal.com/guide/evidence.html)SOLID (https://metamachine.sukanthoriginal.com/guide/evidence.html)TESTED (https://metamachine.sukanthoriginal.com/guide/evidence.html)$0Cyan · tested range   Yellow · base$19.6T

What is being compared?

The base case uses the value of health output allowed as a proxy for approval throughput. Two alternatives use a study's share of health-spending growth attributed to technology to estimate how much growth needs newly approved products. Applying that spending relationship to approval capacity is part of the model's interpretation.

 | Quantity | 2035 amount

 | Needed for the full target | 51,080.9

 | Supply on course | 30,435.4

 | Supply at precedent | 32,810.9

All three use the same input unit — bn 2026 int$ of health output (C05) that must be allowed in 2035.

Show the shortage calculation

Input shortage = maximum of zero and requirement minus supply. Coverage = supply ÷ requirement.

 | Supply path | Input shortfall | Full-target need met

 | On course | 20,645.5 | 59.6%

 | At precedent | 18,270.0 | 64.2%

The physical shortfall and the blocked-output amount use different units. The model converts between them using each layer's input requirements and the allocation described below.

Source files · shortages_v4.csv (https://metamachine.sukanthoriginal.com/data/shortages_v4.csv)

How this becomes blocked output

The model asks two questions. With the whole target attempted, how much tier-2 output must be removed at precedent input supply? With only on-course output and tier 1 attempted, how much tier-1 output must be removed at on-course supply? It adds the resulting tier-2 and tier-1 blocks for this shortage.

$18.3T tier 2 + $1.3T tier 1 = $19.6T blocked

The allocation drops eligible output from the model's most input-intensive layers first and protects the on-course baseline. The ordering is fixed within a test. Labour-dependent requirements are recalculated as output is removed.
Understand the allocation and its limits (https://metamachine.sukanthoriginal.com/guide/methods.html)

See the affected layers

 | Layer | Base output blocked

 | Health care (https://metamachine.sukanthoriginal.com/guide/layer-c05.html) | $19.6T

Other shortages can block these same amounts. Removing a single constraint leaves the other constraints to be tested.

Source files · own_blocks_v4.csv (https://metamachine.sukanthoriginal.com/data/own_blocks_v4.csv)

What changes the answer?

Each row recomputes the constraint under a different production or demand assumption. The displayed range takes the smallest and largest output blocks across all these rows.

 | Case | What changes | Output blocked

 | base | v3 ratio: identity | $19.6T

 | techshare_low | only 27% of health output growth beyond the current-rule path comes from new technology needing approval; the rest is more of approved care | $4.9T

 | techshare_high | only 48% of health output growth beyond the current-rule path comes from new technology needing approval; the rest is more of approved care | $8.8T

See its reported rank in each scenario

 | Scenario | Rank | Output blocked

 | base | 5 | $19.6T

 | AI takes cognitive tasks first | 9 | $19.6T

 | humans keep cognitive tasks | 5 | $19.6T

 | labour productivity on trend | 5 | $19.6T

 | v3 second sourced ratios | 4 | $19.6T

 | 2026 intensities / K-Y trend | 10 | $19.6T

 | land- and approval-saving technology, task reallocation | 11 | $4.9T

The published ranking takes the first matching variant for each scenario. Clinical approval and cropland each have a second S6 variant that appears in the range above and is omitted from those ranking columns.
Read every scenario (https://metamachine.sukanthoriginal.com/guide/scenarios.html)

Growth and the historical comparison

Further health output is workforce (2010-19) and productivity (2015-24) precedents achieved under current approval rules (BL C05-F1, C05-F2); new products not needed

 | Rate | Annual growth

 | Needed to reach the target input | 9.0%

 | Implied by precedent supply | 3.8%

The growth comparison uses a nine-year interval from 2026 to 2035.

Sources and exact values

Source files · shortages_v4.csv (https://metamachine.sukanthoriginal.com/data/shortages_v4.csv) · variants_v4.csv (https://metamachine.sukanthoriginal.com/data/variants_v4.csv) · own_blocks_v4.csv (https://metamachine.sukanthoriginal.com/data/own_blocks_v4.csv)

base · stage1-v3/requirements/requirements.csv (ratio_2035)

techshare_low · searches_v4.csv W2 (Smith, Newhouse, Freeland 2009)

techshare_high · searches_v4.csv W2 (Smith, Newhouse, Freeland 2009)
Open the input files and source registries (https://metamachine.sukanthoriginal.com/guide/sources.html)
